Some studies [8–10] indicated that PD-L1-positive immunoreactivity on tumour cells was a significant predictor of unfavourable overall, disease-free, or recurrence-free survival in colorectal adenocarcinoma. This evidence concerns the gene CD274 and colorectal adenocarcinoma.